Objective: Few studies have reported the influence of clinical background factors on the outcome of Helicobacter pylori eradication therapy in primary care practice. We aimed to determine which clinical background factors influence the outcome of eradication therapy in a primary care setting.
| MATERIAL S AND ME THODS

| Study design, setting, and participants
We conducted a retrospective study to review medical records of 369 patients who received H pylori eradication therapy at Higashiohmi City Gamo Medical Center, Shiga, Japan, from January 2012 to December 2015. The hospital usually provides primary health care with 19 beds in a rural region. Seven physicians including three generalists and four gastroenterology specialists were working at this hospital during the study period. The study was approved by the Ethics Board of Jichi Medical University, Tochigi, Japan (approved on December 2017; approval acceptance No. 17-089).
| Measurements
We investigated patients' background factors associated with three clinical outcomes of H pylori eradication therapy: (a) success, (b) failure, and (c) self-interruption. We determined successful or unsuccessful outcomes by the result of urea breath test after eradication therapy. The self-interruption patients were defined as those who never received any subsequent examinations to determine the outcome of eradication therapy. Patients' background factors included age, gender, treatment status, reasons for receiving gastroenterological endoscopic examination, method of drug administration, and attending physicians' age and their specialties. We divided age group into three categories: 30-49, 50-69, and ≥ 70 years, which were defined as young, middle-aged, and elderly groups, respectively. 
| Statistical analysis
All analyses were performed using IBM SPSS Statistics for Windows, version 24 (IBM Corp., Armonk, NY, USA). Descriptive statistics of the participants were mean ± SD for age, and proportion for all other variables. We conducted logistic regression analyses to determine factors associated with each of the three clinical outcomes. Using univariate analysis, crude odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for all factors. Adjusted ORs (95% CIs) were then obtained, adjusting for all variables. We applied the minimum ORs for each factor as references (ORs = 1) so that the results could be interpreted clearly.
| RE SULTS
| Basic characteristics of the study participants
Basic characteristics of all 369 participants are shown in Table 1 .
Mean age of all patients was 59 ± 12 (range 30-88) years, and mean age of men and women was 58 ± 13 (30-83) and 60 ± 11 (31-88) years, respectively. The percentages of patients by age group 30-49, 50-69, and ≥ 70 years were 24%, 56%, and 20%, respectively. Fifty-six percent of patients were female, and 87% received first-line therapy.
Fifteen percent of patients received endoscopic examination for any symptomatic complaints. Packed formulation drugs were prescribed for 83% patients. With regard to the attending physicians, 69% were aged < 50 years, and 75% were gastroenterological specialists.
All patients were treated by proton pump inhibitor (PPI) with CAM and amoxicillin, or PPI with amoxicillin and metronidazole.
None used vonoprazan. The eradication rate was 79% for first-line therapy and 82% for second-line therapy. Successful eradication rates by age group were 64%, 86%, and 77% for 30-49, 50-69, and ≥ 70 years, respectively. The rates for men and women were 76% and 81%, respectively. Compared with older patients, younger patients had a higher proportion of those with any symptomatic complaints, resulting in detection of H pylori infection and administration of eradication therapy. In contrast, older patients, especially middle-aged patients, had a higher proportion of those who received endoscopic examination for medical checkup.
| Factors associated with clinical outcomes
Factors associated with successful outcome of eradication therapy are shown in Table 2 . The middle-aged group was associated with successful eradication therapy in univariate logistic regression analysis (crude OR = 3.4; 95% CI = 1.8-6.8), compared with the young group. This association was also significant in multivariate analysis after adjusting for all the factors (adjusted OR = 3.5; 95% CI = 1.8-6.8). Table 3 TA B L E 1 Basic characteristic of all 369 participants Table 4 shows factors associated with self-interruption of eradication therapy. The young group was associated with selfinterruption outcome in both univariate (crude OR = 15, 95% CI = 2.0-120) and multivariate (adjusted OR = 11, 95% CI = 1.2-89) logistic regression analyses, compared with older groups. Although symptomatic patients were associated with the self-interruption outcome in univariate analysis (crude OR = 6.1, 95% CI = 1.7-22), the association was not significant after adjusting in multivariate
analysis. There was a marginally significant association between male patients and self-interruption.
The specialty of the attending physicians had no significant associations with all three outcomes of H pylori eradication therapy.
| D ISCUSS I ON
Our results indicated that the middle-aged group compared with other age groups was significantly associated with successful eradication therapy even after adjusting for other factors. Middleaged patients may have been more motivated than other-aged patients because they received eradication therapy via recommendation from their health checkup results more often than other-aged patients did. Additionally, middle-aged patients are usually less likely to forget to take their medication compared with older patients. This is supported by previous studies that have reported that "forgetting to take the drug" was one of the factors involved in treatment failure. 26 This supports our finding that patients aged >70 years were associated with failure of eradication therapy even after adjusting for other factors.
Our study indicated that failure of eradication therapy was affected by attending physicians' factors as well as patients' factors.
Our results showed that older attending physicians (>50 years) were associated with failure. Tsugawa et al 29 investigated the association between 30-day mortality rates and healthcare costs in acute care hospitals, and found that mortality rates were higher among older physicians, which is similar to our results. We did not assess the length of time spent explaining the eradication therapy and the drug regimen. Given that patients prefer experienced physicians with a long career path, older physicians may have less time for each patient, resulting in insufficient explanation of eradication therapy, which may adversely affect outcome.
Our results indicated that elderly patients aged >70 years were at high risk for H pylori eradication therapy failure compared with other-aged patients. Elderly patients generally have many medications prescribed, often suffer from cognitive decline, and frequently have physical limitations, which would affect their medication compliance and possibly result in unsuccessful outcome of therapies. 30 Nevertheless, Mamori et al 31 previously investigated the general risk factors that affected outcome of eradication therapy in Japanese patients, and found that the success rate in patients aged >70 years were over 90%, which was higher than those in younger-aged groups. This report was contrary to our findings. Our study included patients aged >70 years more than those in the previous study, which might lead to the opposite results. Older attending physicians (>50 years) might be mostly assigned to elderly patients in our study, which could confound the results. Study setting might influence the results; our study was conducted in a small hospital located in a rural region. Further study is required to assess whether the differences would occur related to patients' characteristics as well as study settings, using a large-scale dataset. However, >20 years have passed since then, and eradication therapy is now an important routine practice even among generalists. 38 In our study, no difference was found between generalists and gastroenterologists in the outcome of eradication therapy. Given that patients' compliance affects the results of eradication therapy, generalists could achieve comparable or better outcomes than gastroenterological specialists. Another previous study reported that medical specialists and generalists served different primary care roles for different populations, and found that generalists saw younger patients most often for new problems, compared with specialists. 39 Generalists may influence younger patients to refrain from self-interruption of eradication therapy more often than gastroenterologists do. physicians, which could have caused beta errors in the statistical
